REG - Hikma Pharmaceutical - Director/PDMR Shareholding
Tue 12:45
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260602:nRSB6794Ga&default-theme=true
RNS Number : 6794G Hikma Pharmaceuticals Plc 02 June 2026
Hikma Pharmaceuticals PLC - LTIP and EIP Vesting
LONDON, 2 June 2026: Hikma Pharmaceuticals PLC (LSE: HIK) (Nasdaq Dubai: HIK)
("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons
Discharging Managerial Responsibility ("PDMRs") have received shares as a
result of the vesting of their conditional share awards which were granted on
30 May 2023 under the 2023 Long-Term Incentive Plan ("LTIP") and 2014
Executive Incentive Plan ("EIP") Element C.
Notification and public disclosure of transactions by Persons Discharging
Managerial Responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards under the LTIP and EIP.
All shares were retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 91,812
Nil EIP Award, Element C: 19,761
d) Aggregated information Price(s): nil
Volume(s): 111,573
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman and Deputy CEO, MENA
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards under the LTIP and EIP.
All shares were retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 72,763
Nil EIP Award, Element C: 20,650
d) Aggregated information Price(s): nil
Volume(s): 93,413
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status Deputy CEO, North America and Europe
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards under the LTIP and EIP.
All shares were retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 51,650
Nil EIP Award, Element C: 22,209
d) Aggregated information Price(s): nil
Volume(s): 73,859
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
Bassam Kanaan
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards under the LTIP and EIP.
All shares were retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 52,640
Nil EIP Award, Element C: 20,982
d) Aggregated information Price(s): nil
Volume(s): 73,622
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards under the LTIP and EIP.
All shares were retained.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 28,631
Nil EIP Award, Element C: 12,406
d) Aggregated information Price(s): nil
Volume(s): 41,037
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
Susan Ringdal
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction Shares acquired from the vesting of conditional awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 26,558
Nil EIP Award, Element C: 11,664
d) Aggregated information Price(s): nil
Volume(s): 38,222
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each ("Shares")
code
ID Code: GB00B0LCW083
b) Nature of the transaction All shares sold following the vesting of conditional awards under the LTIP and
EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
£14.49 LTIP Award: 26,558
£14.49 EIP Award, Element C: 11,664
d) Aggregated information Price(s): £14.49
Volume(s): 38,222
Total(s): £553,748.83
e) Date of the transaction 1 June 2026
f) Place of the transaction London Stock Exchange (XLON)
Helen Middlemist
Group Company Secretary
+44 (0)20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBBGDLBSGDGLD
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement